Evidence map›Paper›PMID 32233022›Full record

ArticleJournal of cellular and molecular medicine2020

To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.

Jiazhi Jiang, Yaqiong Bi, Xiao-Ping Liu, Donghu Yu, Xin Yan, Jie Yao, Tongzu Liu, Sheng Li

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Immune-related ceRNA Network in Prognosis of Cervical Cancer.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in cell and developmental biology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jiazhi JiangDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yaqiong BiDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xiao-Ping LiuDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Donghu YuDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xin YanDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jie YaoDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Tongzu LiuDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Sheng LiDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.ORCID 0000-0003-4070-7345
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging evidence demonstrates that competing endogenous RNA (ceRNA) hypothesis has played a role in molecular biological mechanisms of cancer occurrence and development. But the effect of ceRNA network in bladder cancer (BC), especially lncRNA-miRNA-mRNA regulatory network of BC, was not completely expounded. By means of The Cancer Genome Atlas (TCGA) database, we compared the expression of RNA sequencing (RNA-Seq) data between 19 normal bladder tissue and 414 primary bladder tumours. Then, weighted gene co-expression network analysis (WGCNA) was conducted to analyse the correlation between two sets of genes with traits. Interactions between miRNAs, lncRNAs and target mRNAs were predicted by MiRcode, miRDB, starBase, miRTarBase and TargetScan. Next, by univariate Cox regression and LASSO regression analysis, the 86 mRNAs obtained by prediction were used to construct a prognostic model which contained 4 mRNAs (ACTC1 + FAM129A + OSBPL10 + EPHA2). Then, by the 4 mRNAs in the prognostic model, a ceRNA regulatory network with 48 lncRNAs, 14 miRNAs and 4 mRNAs was constructed. To sum up, the ceRNA network can further explore gene regulation and predict the prognosis of BC patients.

Indexed as

Gene Regulatory NetworksAgedBiomarkers, TumorFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene OntologyHumansMaleMiddle AgedPrognosisProportional Hazards ModelsReproducibility of ResultsRisk FactorsRNA, Long NoncodingRNA, MessengerBiomarkers, TumorRNA, Long NoncodingRNA, MessengerRNA, Neoplasmbladder cancerceRNAco-expression networkprognostic marker

Identifiers

PMID32233022
PMCPMC7205833
OpenAlexW3013959886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.